MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

194.20 -3.94 (-1.99%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 904,098
Open 199.70
Bid (Size) 178.52 (100)
Ask (Size) 205.00 (500)
Prev. Close 198.14
Today's Range 192.32 - 200.00
52wk Range 97.50 - 200.24
Shares Outstanding 62,311,104
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Lilly’s $7.8 Billion Centessa Bet: Inside the Race to Dominate the Sleep Market’s ‘Orexin Gold Rush’
On March 31, 2026, Eli Lilly and Company (NYSE:LLY) sent shockwaves through the biotechnology sector by announcing a definitive agreement to acquire Centessa Pharmaceuticals (Nasdaq:CNTA) for a total... 
Via MarketMinute
News headline image
The Orexin Gold Rush: Deep Dive into Eli Lilly’s $7.8 Billion Acquisition of Centessa Pharmaceuticals
Today, March 31, 2026, the biotechnology landscape has been fundamentally reshaped. Eli Lilly and Company (NYSE: LLY) has officially announced a definitive agreement to acquire Centessa Pharmaceuticals... 
Via Finterra
Topics Economy Initial Public Offering Intellectual Property

Performance

YTD
+12.2%
+12.2%
1 Month
+7.7%
+7.7%
3 Month
+18.6%
+18.6%
6 Month
+43.7%
+43.7%
1 Year
+93.2%
+93.2%

More News

Read More
JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) Beats Q4 Estimates but 2026 Guidance Tempers Gains ↗
Via Chartmill
News headline image
1 Value Stock to Research Further and 2 We Ignore
Via StockStory
News headline image
3 Healthcare Stocks Walking a Fine Line
Via StockStory
News headline image
Zymeworks (ZYME) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 CY2025 Sales
Via StockStory
News headline image
Jazz Pharmaceuticals Earnings: What To Look For From JAZZ
Via StockStory
Topics Artificial Intelligence Government World Trade
News headline image
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off
Via StockStory
News headline image
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid
Via StockStory
News headline image
3 Cash-Producing Stocks We Think Twice About
Via StockStory
News headline image
$100 Million Exit: Why One Fund Walked Away From a Chinese E-Commerce Stock Up 24% ↗
Via The Motley Fool
Topics Economy
News headline image
This Bank Stock Just Saw a $24 Million Fund Sale, but Here's Why It's Still a Top Holding ↗
Via The Motley Fool
Topics Credit Cards ETFs
News headline image
Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed? ↗
Via The Motley Fool
Topics Initial Public Offering Intellectual Property
News headline image
3 of Wall Street’s Favorite Stocks We Think Twice About
Via StockStory
News headline image
3 Small-Cap Stocks That Fall Short
Via StockStory
Topics Electric Vehicles
News headline image
Reflecting On Pharmaceuticals Stocks’ Q3 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ)
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Mid-Cap Stocks with Warning Signs
Via StockStory
News headline image
3 Reasons JAZZ is Risky and 1 Stock to Buy Instead
Via StockStory
Topics Bankruptcy
News headline image
3 Value Stocks We’re Skeptical Of
Via StockStory
News headline image
This Biotech Fund Just Made a $22 Million Bet on Pharvaris Stock — Is It a Buy? ↗
Via The Motley Fool
News headline image
Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow? ↗
Via The Motley Fool
News headline image
Why a Biotech Fund Made Dyne Therapeutics One of Its Biggest Stock Bets ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Healthcare Stocks We’re Skeptical Of
Via StockStory
Topics Stocks

Frequently Asked Questions

Is Jazz Pharmaceuticals plc - Ordinary Shares publicly traded?
Yes, Jazz Pharmaceuticals plc - Ordinary Shares is publicly traded.
What exchange does Jazz Pharmaceuticals plc - Ordinary Shares trade on?
Jazz Pharmaceuticals plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares?
The ticker symbol for Jazz Pharmaceuticals plc - Ordinary Shares is JAZZ on the Nasdaq Stock Market
What is the current price of Jazz Pharmaceuticals plc - Ordinary Shares?
The current price of Jazz Pharmaceuticals plc - Ordinary Shares is 194.20
When was Jazz Pharmaceuticals plc - Ordinary Shares last traded?
The last trade of Jazz Pharmaceuticals plc - Ordinary Shares was at 04/10/26 04:00 PM ET
What is the market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares?
The market capitalization of Jazz Pharmaceuticals plc - Ordinary Shares is 12.10B
How many shares of Jazz Pharmaceuticals plc - Ordinary Shares are outstanding?
Jazz Pharmaceuticals plc - Ordinary Shares has 12B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story